Pauline Hyman‐Taylor

Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis—the TOPIC study: a randomised controlled trial

Alan R Smyth, Kelvin H-V Tan, Pauline Hyman‐Taylor et al. · The Lancet · 2005 · 225 citations

Pulmonary Care, Advanced Lung Disease, Pulmonary Exacerbations +6

Absence of Cochleotoxicity Measured by Standard and High-Frequency Pure Tone Audiometry in a Trial of Once- versus Three-Times-Daily Tobramycin in Cystic Fibrosis Patients

M. Mulheran, Pauline Hyman‐Taylor, Kelvin H-V Tan et al. · Antimicrobial Agents and Chemotherapy · 2006 · 43 citations · Full text

Pediatric Otolaryngology, Cystic Fibrosis Patients, Audiology +8

Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis?the TOPIC study: a randomised controlled trial

Alan R Smyth, Kok Hian Tan, Pauline Hyman‐Taylor et al. · The Lancet · 2005 · 39 citations

Pulmonary Pharmacology, Pulmonary Fibrosis, Pulmonary Medicine +4

A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancer

John F. R. Robertson, J. Michael Dixon, D.M. Sibbering et al. · Breast Cancer Research · 2013 · 35 citations · Full text